Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)
| Conditions: | Malignant Pleural Mesothelioma|MPM|Solid Tumors |
| Start Date: | May 1, 2008 |
| Phase: | Phase I|Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00700336 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed, cisplatin and CBP501|Drug: pemetrexed and cisplatin |
| Study Design: | Allocation: Randomized|Control: Active Control|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | CanBas Co. Ltd. |
| Ages: | Adult|Senior |
| Enrollment: | 72 |
| Funded By: | Industry |
| First Received: | June 16, 2008 |
| End Date: | |
| Last Updated: | August 16, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
